Interestingly, when GBM xenograft cells including D456MG were grown in 1% hypoxia to simulate the more severe physiologic hypoxic environment that glioma cells experience in vivo, nectin-1 expression increased significantly (12% increase in D456MG cells; Friedman et al., 2012a). The gene discussed is NECTIN1; the disease is central nervous system cancer.